Luis Ramón

ORCID: 0000-0002-5789-4506 · 13 papers in corpus · active 2003-2013

Study types

  • article 12
  • review 1

Condition tags

  • endometriosis 13
  • mesh:D004715 6
  • endometrioma 3
article 2013
Peritoneal Fluid Reduces Angiogenesis-Related MicroRNA Expression in Cell Cultures of Endometrial and Endometriotic Tissues from Women with Endometriosis
PloS one ·doi:10.1371/journal.pone.0062370

UNLABELLED: Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent gynecological diseases. It has been suggested that modifications of both endometrial and peritoneal factors could be implicate…

article 2012
C0080 Influence of peritoneal fluid on micrornas related to angiogenesis and angiogenic and fibrinolytic factors expression in stromal cell cultures of eutopic endometria and ovarian endometriomas from women with endometriosis
·doi:10.1016/j.thromres.2012.08.021
article 2012
C0081 Tissue factor expression and micrornas −17-5p and –20a in endometrial cell cultures from women with endometriosis: Its modulation by peritoneal fluid
·doi:10.1016/j.thromres.2012.08.022
review 2012
Role of microRNAs in Gynecological Pathology
Current medicinal chemistry ·doi:10.2174/092986712800269362

microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate gene expression and play fundamental roles in biological processes. These small molecules bind to target mRNAs, leading to translational repression and/or mRNA degradatio…

article 2011
microRNAs expression in endometriosis and their relation to angiogenic factors
Human Reproduction ·doi:10.1093/humrep/der025

BACKGROUND: Endometriosis is a common, multifactorial disease in which angiogenesis may be involved in the growth of endometrium outside the uterus. microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate gene expression and p…

article 2011
microRNAs Expression in Endometriosis and Their Relation to Angiogenic Factors
·doi:10.1097/ogx.0b013e31824021f9

Despite the high prevalence of endometriosis and its incapacitating symptoms, pathogenic mechanisms of this multifactorial disease are unclear. A number of studies have reported that angiogenesis may play an important role in the growth of …

article 2009
Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis
Human Reproduction ·doi:10.1093/humrep/dep419

BACKGROUND: Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent benign gynaecological diseases. It has been suggested that both endometrial and peritoneal factors, related to angiogenesis an…

article 2009
O4 Vascular endothelial growth factor (VEGF) polymorphisms (−460C/T, +405G/C and 936C/T) and endometriosis. Their influence on VEGF expression
·doi:10.1016/s0049-3848(09)70029-5
article 2008
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression
Thrombosis research ·doi:10.1016/j.thromres.2008.02.010
article 2008
Vascular endothelial growth factor polymorphisms (−460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.08.079
article 2007
ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (−460CT, 405GC AND 936CT) IN VEGF EXPRESSION
·doi:10.1111/j.1538-7836.2007.tb00521.x
article 2004
mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT–PCR assay
Human Reproduction ·doi:10.1093/humrep/deh571

BACKGROUND: The plasminogen activator (PA) and matrix metalloproteinase (MMP) systems are implicated in the establishment of endometriosis. The mechanisms by which these systems are involved in the pathogenesis of this disease are not well …

article 2003
Quantitative real-time reverse transcription-PCR (RT-PCR) assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 and tissue metalloproteinase inhibitor type 1 gene expression and protein levels in endometriosis
·doi:10.1111/j.1538-7836.2003.tb04369.x